custom image

Advances in Cancer Immunotherapy

August 17–19, 2020 | 10:00AM EDT | 2:00PM UTC | 4:00PM CEST*
*Program is subject to change


You must be registered to view on demand content. Plenary presentations and roundtable recordings are available on-demand 24 to 48 hours after the event. Registrants may access this content anytime for up to 9 months following the event.

Cancer immunotherapy provides unprecedented long-term antitumor activity in some patients, however the majority of patients with advanced cancers only experience short-term remission. To achieve better outcomes for everyone will require a mechanistic understanding of response, and resistance, to these therapies, including immune inhibitory checkpoint blockade and T-cell engineering. These insights will provide rationale for how to best combine these therapeutic approaches for sustained clinical success.

In this virtual meeting we will tackle many of these unanswered questions in the field, including:

  • How do cancers adapt and resist T cell attack?
  • Can we better understand the tumor microenvironment to pave the way for new approaches to immunotherapy?
  • What is the rationale behind immune-oncology (IO) combinations in clinical testing?

The program highlights novel methodologies, data-analysis techniques, and tools to integrate high throughput and patient-derived sample data, revealing powerful new approaches to understand both genetic and adaptive resistance mechanisms, and ways to overcome them. The largest human experiment to date is currently underway, testing over 1,000 agents and combinations; examining preliminary results will be key to refining our approaches, and understanding of immunity in patients with cancer.

Overall, participants will gain a more comprehensive understanding of tumor immunology, and how to leverage this knowledge to outsmart tumors and achieve lasting remission in patients. In addition, the virtual event provides a platform for trainees, junior researchers, and rising stars in the field to share promising new directions that will progress the field forward, towards new and innovative breakthroughs.

Keystone Symposia conferences provide unique opportunities for trainees and junior researchers to present their work to global audiences and field leaders. The eSymposia platform continues this strong tradition of providing these critical career-development and advancement experiences for the next-generation, incorporating short talks and ePoster sessions to highlight rising stars in the field.

Submit your work to be featured in an ePoster session alongside world leaders!


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Scholarships: Passed
Abstract Submission: Passed


Program Details

Keynote Speaker

James P. Allison

University of Texas MD Anderson Cancer Center

Immune Checkpoint Blockade in Cancer Therapy:
New Insights into Therapeutic Mechanisms

Editors Attending This Meeting

custom image custom image
Gaia Trincucci, PhD Scientific Editor, Journal of Experimental Medicine (JEM)
Teodoro-Pulvirenti, PhD Executive Editor, Journal of Experimental Medicine (JEM)

Speaking at this eSymposia

Coralie Backlund

Massachusetts Institute of Technology

custom image

Katie Campbell

University of California, Los Angeles

Yvonne Y. Chen

University of California, Los Angeles

Shira Tabachnick-Cherny

University of Washington

AHyun Choi

Novartis Institutes for BioMedical Research

Kelli Connolly

Yale University

Nadine A. Defranoux

Parker Institute for Cancer Immunotherapy

James R. Heath

Institute for Systems Biology


custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image
custom image

Additional Support

custom image
custom image

Funding for this conference was made possible (in part) by 1R13CA246936-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Media In-Kind Sponsors

custom image

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image
custom image
custom image

Donate to Keystone Symposia

custom image